Media Hub

Jun 2019

Pioneering ‘living drug’ gives hope to terminal blood cancer patients

A new pioneering treatment has been offered to lymphoma patients which genetically re-programmes their immune system to fight cancer. The new CAR-T therapy, is a ‘living drug- which is personalised to each patient by using their body’s own cells. The process involves with removal of white blood cells, also known as T-cells, from the patient’s…

Read More